Aspirina y heparinas de bajo peso molecular. Tromboprofilaxis

• Autores: Guillermo María Castaño Doste, María Belén Castaño Doste, Alvaro Comps Almunia, Danae Comps Almunia, Esther Trillo Sallán, Alejandro Berdiel Cistero
• Localización: Revista Sanitaria de Investigación, ISSN-e 2660-7085, Vol. 5, Nº. 11, 2024
• Idioma: español
• Enlaces
  • Texto completo
• Resumen
  • español

    La tromboprofilaxis es esencial en la prevención del tromboembolismo venoso (TEV) en pacientes quirúrgicos. La aspirina y las heparinas de bajo peso molecular (HBPM) son los agentes profilácticos utilizados comúnmente.

  • English

    Thromboprophylaxis is essential in preventing venous thromboembolism (VTE) in surgical patients. Aspirin and low molecular weight heparins (LMWH) are commonly used.

• Referencias bibliográficas
  • Anderson DR, Dunbar MJ, Bohm ER, et al. Aspirin or Rivaroxaban for VTE Prophylaxis after Hip or Knee Arthroplasty. N Engl J Med. 2018;378(8):699-707.
  • González Della Valle A, Besculides MC, Sharrock N, Sculco TP. Thromboembolic prophylaxis after total hip arthroplasty: aspirin,warfarin, enoxaparin,...
  • Gomez-Outes A, Terleira-Fernandez AI, Suarez-Gea ML, Vargas-Castrillon E. Direct oral anticoagulants in the treatment of acute venous thromboembolism:...
  • Hull RD, Schellong SM. Prophylaxis of venous thromboembolic events in patients with medical illness: where do we stand? Semin Thromb Hemost....
  • Faour M, Piuzzi NS, Brigati DP, Klika AK, Mont MA, Barsoum WK, Higuera CA. Comparative efficacy and safety of aspirin versus low molecular...
  • Drescher FS, Sirovich BE, Lee A, Morrison DH, Chiang WH, Larson RJ. Aspirin versus low molecular weight heparin for extended venous thromboembolism...
  • Jameson SS, Baker PN, Deehan DJ, Port A, Tucker K, Reed MR. Evidence base for aspirin as venous thromboembolic prophylaxis following joint...
  • Anderson DR, Dunbar MJ, Bohm ER, et al. Aspirin versus low molecular weight heparin for extended venous thromboembolism prophylaxis after...